Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • Topics
  • AMD
  • DME
  • Uveitis
  • Diabetic Retinopathy
  • Ophthalmology Times
MJH Life Sciences

SUBSCRIBE: eNewsletter

Obesity + diabetic retinopathy: Korean study explores inverse association

A Korean study identified an inverse association between vision-threatening diabetic retinopathy and body fat in patients with type 2 diabetes.

Recent Content

Medicare Part B beneficiaries

Tracking anti-VEGF use among Medicare Part B beneficiaries

December 3, 2019
  • Michelle Dalton, ELS

Anti-vascular endothelial growth factor (VEGF) agents—including aflibercept, bevacizumab, and ranibizumab—have ushered in a new era in the treatment of retinal and choroidal neovascularization.

Patient assistance programs available for patients with DME

November 21, 2019
  • Michelle Dalton, ELS

Patient adherence to treatment can sometimes be tricky—especially when out-of-pocket costs are considered.

Early intervention best for patients with diabetic eye diseases

November 21, 2019
  • Michelle Dalton, ELS

When it comes to diabetic eye diseases, there are a multitude of potential treatments—but perhaps the “easiest” one for patients is to ensure their A1C levels are under control.1

Myopia may prove beneficial in preventing DR development

November 18, 2019
  • Michelle Dalton, ELS

New research has shown that a longer axial length (AL) may prove protective of incident diabetic retinopathy (DR).1

Ultra-widefield OCT ‘may be the only imaging’ needed to manage PDR

November 15, 2019
  • Michelle Dalton, ELS

Proliferative diabetic retinopathy (PDR) is defined by the presence of neovascularization; the use of ultra-widefield (UWF) imaging has shown the distribution of this neovascularization and other diabet

Guidelines for treating the diabetic eye patient

November 14, 2019
  • Michelle Dalton, ELS

The most consistent means to lower the risk of developing complications from diabetes is for people to maintain good glycemic control.1 The new current criteria for the diagnosis of diabetes now in

Anti-VEGF injections and glaucoma: Surgeons must watch IOP elevation

November 12, 2019
  • Louise Gagnon

Anti-VEGF injections may be associated with acute IOP spikes and chronic IOP rise in patients, and these increases in IOP need to be acknowledged and managed, according to Matthew Schlenker MD, MSc.

Central subfield thickness only partially responsible for changes in acuity

November 7, 2019
  • Michelle Dalton, ELS

A post-hoc analysis of Protocol T from the DRCR Retina Network, which compared anti-vascular endothelial growth factor (VEGF) compounds aflibercept, bevacizumab, and r

Risk factors and recommendations for DR, DME

November 7, 2019
  • Michelle Dalton, ELS

According to a 2018 American Eye-Q  Survey conducted by the American

AMD risk phenotypes targeted in direct-to-consumer genetic database

November 4, 2019
  • Cheryl Guttman Krader

Genetic testing can identify patients with high-risk genotypes for

Browse more articles

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • AMD Awareness
  • DME
  • AMD Nurturing Program
  • Diabetic Eye Awareness
  • Wet AMD
Partner Perspective: Patient Case Study - CONTINUOUS MICRODOSING™ TREATMENT WITH ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19mg
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".